285 related articles for article (PubMed ID: 30166241)
1. Membrane Stabilization by Modified Steroid Offers a Potential Therapy for Muscular Dystrophy Due to Dysferlin Deficit.
Sreetama SC; Chandra G; Van der Meulen JH; Ahmad MM; Suzuki P; Bhuvanendran S; Nagaraju K; Hoffman EP; Jaiswal JK
Mol Ther; 2018 Sep; 26(9):2231-2242. PubMed ID: 30166241
[TBL] [Abstract][Full Text] [Related]
2. Annexin A2 links poor myofiber repair with inflammation and adipogenic replacement of the injured muscle.
Defour A; Medikayala S; Van der Meulen JH; Hogarth MW; Holdreith N; Malatras A; Duddy W; Boehler J; Nagaraju K; Jaiswal JK
Hum Mol Genet; 2017 Jun; 26(11):1979-1991. PubMed ID: 28334824
[TBL] [Abstract][Full Text] [Related]
3. Treatment with Recombinant Human MG53 Protein Increases Membrane Integrity in a Mouse Model of Limb Girdle Muscular Dystrophy 2B.
Gushchina LV; Bhattacharya S; McElhanon KE; Choi JH; Manring H; Beck EX; Alloush J; Weisleder N
Mol Ther; 2017 Oct; 25(10):2360-2371. PubMed ID: 28750735
[TBL] [Abstract][Full Text] [Related]
4. Secreted acid sphingomyelinase as a potential gene therapy for limb girdle muscular dystrophy 2B.
Bittel DC; Sreetama SC; Chandra G; Ziegler R; Nagaraju K; Van der Meulen JH; Jaiswal JK
J Clin Invest; 2022 Jan; 132(1):. PubMed ID: 34981776
[TBL] [Abstract][Full Text] [Related]
5. Increased nonHDL cholesterol levels cause muscle wasting and ambulatory dysfunction in the mouse model of LGMD2B.
Sellers SL; Milad N; White Z; Pascoe C; Chan R; Payne GW; Seow C; Rossi F; Seidman MA; Bernatchez P
J Lipid Res; 2018 Feb; 59(2):261-272. PubMed ID: 29175948
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria mediate cell membrane repair and contribute to Duchenne muscular dystrophy.
Vila MC; Rayavarapu S; Hogarth MW; Van der Meulen JH; Horn A; Defour A; Takeda S; Brown KJ; Hathout Y; Nagaraju K; Jaiswal JK
Cell Death Differ; 2017 Feb; 24(2):330-342. PubMed ID: 27834955
[TBL] [Abstract][Full Text] [Related]
7. Bioengineered Model of Human LGMD2B Skeletal Muscle Reveals Roles of Intracellular Calcium Overload in Contractile and Metabolic Dysfunction in Dysferlinopathy.
Khodabukus A; Prabhu NK; Roberts T; Buldo M; Detwiler A; Fralish ZD; Kondash ME; Truskey GA; Koves TR; Bursac N
Adv Sci (Weinh); 2024 Jun; ():e2400188. PubMed ID: 38887849
[TBL] [Abstract][Full Text] [Related]
8. Considering the Promise of Vamorolone for Treating Duchenne Muscular Dystrophy.
Grounds MD; Lloyd EM
J Neuromuscul Dis; 2023; 10(6):1013-1030. PubMed ID: 37927274
[TBL] [Abstract][Full Text] [Related]
9. Dysferlin deficiency enhances monocyte phagocytosis: a model for the inflammatory onset of limb-girdle muscular dystrophy 2B.
Nagaraju K; Rawat R; Veszelovszky E; Thapliyal R; Kesari A; Sparks S; Raben N; Plotz P; Hoffman EP
Am J Pathol; 2008 Mar; 172(3):774-85. PubMed ID: 18276788
[TBL] [Abstract][Full Text] [Related]
10. Blockade of Hemichannels Normalizes the Differentiation Fate of Myoblasts and Features of Skeletal Muscles from Dysferlin-Deficient Mice.
Cea LA; Fernández G; Arias-Bravo G; Castillo-Ruiz M; Escamilla R; Brañes MC; Sáez JC
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825681
[TBL] [Abstract][Full Text] [Related]
11. Limb-girdle muscular dystrophy type 2B causes HDL-C abnormalities in patients and statin-resistant muscle wasting in dysferlin-deficient mice.
White Z; Sun Z; Sauge E; Cox D; Donen G; Pechkovsky D; Straub V; Francis GA; Bernatchez P
Skelet Muscle; 2022 Nov; 12(1):25. PubMed ID: 36447272
[TBL] [Abstract][Full Text] [Related]
12. Myofibers deficient in connexins 43 and 45 expression protect mice from skeletal muscle and systemic dysfunction promoted by a dysferlin mutation.
Fernández G; Arias-Bravo G; Bevilacqua JA; Castillo-Ruiz M; Caviedes P; Sáez JC; Cea LA
Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165800. PubMed ID: 32305450
[TBL] [Abstract][Full Text] [Related]
13. Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency.
Ho M; Post CM; Donahue LR; Lidov HG; Bronson RT; Goolsby H; Watkins SC; Cox GA; Brown RH
Hum Mol Genet; 2004 Sep; 13(18):1999-2010. PubMed ID: 15254015
[TBL] [Abstract][Full Text] [Related]
14. Lack of correlation between outcomes of membrane repair assay and correction of dystrophic changes in experimental therapeutic strategy in dysferlinopathy.
Lostal W; Bartoli M; Roudaut C; Bourg N; Krahn M; Pryadkina M; Borel P; Suel L; Roche JA; Stockholm D; Bloch RJ; Levy N; Bashir R; Richard I
PLoS One; 2012; 7(5):e38036. PubMed ID: 22666441
[TBL] [Abstract][Full Text] [Related]
15. A promotive effect for halofuginone on membrane repair and synaptotagmin-7 levels in muscle cells of dysferlin-null mice.
Barzilai-Tutsch H; Dewulf M; Lamaze C; Butler Browne G; Pines M; Halevy O
Hum Mol Genet; 2018 Aug; 27(16):2817-2829. PubMed ID: 29771357
[TBL] [Abstract][Full Text] [Related]
16. Treatment with galectin-1 improves myogenic potential and membrane repair in dysferlin-deficient models.
Vallecillo-Zúniga ML; Rathgeber MF; Poulson PD; Hayes S; Luddington JS; Gill HN; Teynor M; Kartchner BC; Valdoz J; Stowell C; Markham AR; Arthur C; Stowell S; Van Ry PM
PLoS One; 2020; 15(9):e0238441. PubMed ID: 32881965
[TBL] [Abstract][Full Text] [Related]
17. Defective membrane repair in dysferlin-deficient muscular dystrophy.
Bansal D; Miyake K; Vogel SS; Groh S; Chen CC; Williamson R; McNeil PL; Campbell KP
Nature; 2003 May; 423(6936):168-72. PubMed ID: 12736685
[TBL] [Abstract][Full Text] [Related]
18. Dysferlin regulates cell membrane repair by facilitating injury-triggered acid sphingomyelinase secretion.
Defour A; Van der Meulen JH; Bhat R; Bigot A; Bashir R; Nagaraju K; Jaiswal JK
Cell Death Dis; 2014 Jun; 5(6):e1306. PubMed ID: 24967968
[TBL] [Abstract][Full Text] [Related]
19. Myofiber damage precedes macrophage infiltration after in vivo injury in dysferlin-deficient A/J mouse skeletal muscle.
Roche JA; Tulapurkar ME; Mueller AL; van Rooijen N; Hasday JD; Lovering RM; Bloch RJ
Am J Pathol; 2015 Jun; 185(6):1686-98. PubMed ID: 25920768
[TBL] [Abstract][Full Text] [Related]
20. Serum exosomes can restore cellular function
Dong X; Gao X; Dai Y; Ran N; Yin H
Theranostics; 2018; 8(5):1243-1255. PubMed ID: 29507617
[No Abstract] [Full Text] [Related]
[Next] [New Search]
